Form 4: Atara Biotherapeutics EVP, CFO Eric J. Hyllengren Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Eric J. Hyllengren, EVP and CFO of Atara Biotherapeutics, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Eric J. Hyllengren, the EVP and CFO of Atara Biotherapeutics, sold 28,648 shares of common stock on May 16, 2024.
- The shares were sold at a price of $0.617 per share.
- The sale was executed automatically to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Hyllengren directly owns 645,671 shares of Atara Biotherapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of stock sale transaction. |
| 05/20/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.